WASHINGTON – The US health watchdog FDA is conducting a detailed inspection of the arsenic level in rice being sold in the American market, including those of basmati variety imported from India.
While an analytical study of more than 1,300 samples of rice and rice products, including basmati from India, did not show any alarming levels of arsenic presence, the FDA will now conduct a “comprehensive risk assessment” study to determine the long-term impact of the arsenic found in rice.
Arsenic is a chemical element present in the environment from both natural and human sources and its inorganic forms have been closely associated with long-term health effects such as higher rates of skin, bladder and lung cancers.
While most crops don’t readily take up much arsenic from the ground, rice is different because it takes up arsenic from soil and water more readily than other grains.
In a latest consumer update, the FDA (Food and Drug Administration) said it has “increased its testing of rice and rice products” to determine the level and types of arsenic found in these products, usually a life-long dietary staple.
The regulator said its next step will be “to conduct a risk assessment”, wherein it would analyse the health risk associated with eating rice and rice products to determine the steps required to minimise the risks for consumers, including vulnerable groups like children and pregnant women.
The draft risk assessment will be made available for public comment following peer review, it said.
